Isis Soars on Cholesterol-Drug News
Drugmakers appear to be taking steps forward in their battle to save people from unhealthy levels of cholesterol. Isis Pharmaceuticals (ISIS) shares surged more than 26% Nov. 13 after the company announced positive results in two studies of its cholesterol drug "ISIS 301012."
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.